Скачать или смотреть Who’s Driving Treatment? Two Co-Occurring Driver Mutations in Primary Lung Adenocarcinoma

CGC 2022 Technologist Award - Who’s Driving Treatment? Two Co-Occurring Driver Mutations in Primary Lung Adenocarcinoma (Abstract 38)
Danielle Salari - 2022 CGC Annual Meeting

The Cancer Genomics Consortium (CGC - https://cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. Our vision is for all cancer patients to be accurately diagnosed for their underlying genomic alterations to help them receive the most appropriate therapy. CGC aims to be the authoritative organization for guidance on the best practice of clinical cancer genomic testing. Please visit https://www.cancergenomics.org/become... to become a member and gain full access to our complete library of presentations.